Financhill
Back

Regeneron Pharmaceuticals Vs. Biogen Industry Stock Comparison

Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
748.65
Seasonality Move:
14.6%
Sell
26

BIIB
Biogen

Last Price:
158.09
Seasonality Move:
12.81%
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $743.35. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

  • The current Biogen [BIIB] share price is $156.00. The Score for BIIB is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $743.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

BIIB Stock Price Chart

What is Biogen's stock price today?

  • The Biogen share price today is $156.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -62 Sell
Relative Strength Index (14 RSI): 13.08 Sell
Chaikin Money Flow: 151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (783.29 - 941.63) Sell
Bollinger Bands (100): (917.99 - 1161.21) Sell

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.82 Sell
Relative Strength Index (14 RSI): 19.08 Sell
Chaikin Money Flow: 1376294 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (164.6 - 184.8) Sell
Bollinger Bands (100): (179.33 - 217.01) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 780.04 Sell
20-day SMA: 834.53 Sell
50-day SMA: 964.64 Sell
200-day SMA: 1003.34 Sell
8-day EMA: 775.42 Sell
20-day EMA: 832.12 Sell
50-day EMA: 927.66 Sell
200-day EMA: 978.17 Sell

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 162.54 Sell
20-day SMA: 171.75 Sell
50-day SMA: 183.57 Sell
200-day SMA: 208.91 Sell
8-day EMA: 161.79 Sell
20-day EMA: 169.87 Sell
50-day EMA: 181.53 Sell
200-day EMA: 208.1 Sell

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

Biogen Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $0.26 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):